Bleichroeder LP Dia Medica Therapeutics Inc. Transaction History
Bleichroeder LP
- $292 Million
- Q1 2025
A detailed history of Bleichroeder LP transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Bleichroeder LP holds 382,317 shares of DMAC stock, worth $1.57 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
382,317
Previous 382,317
-0.0%
Holding current value
$1.57 Million
Previous $2.02 Million
28.39%
% of portfolio
0.5%
Previous 0.63%
Shares
3 transactions
Others Institutions Holding DMAC
# of Institutions
62Shares Held
6.06MCall Options Held
14.9KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA1.35MShares$5.55 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$2.49 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX600KShares$2.47 Million5.72% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$2.29 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny337KShares$1.38 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $109M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...